435074 Tunable Composite Nanocarriers for Magnetic Resonance Imaging, Multi-Modal Imaging and Theranostic Applications

Thursday, November 12, 2015: 12:30 PM
253B (Salt Palace Convention Center)
Robert K. Prud'homme, Chemical and Biological Engineering, Princeton University, Princeton, NJ

MRI and NIR-active, multi-modal and theranostic Composite NanoCarriers (CNCs) have been

developed using a simple one-step process, Flash NanoPrecipitation (FNP). The CNCs have higher MRI T2 contrast

and drug loading than have been reported for carriers produced by more complex assembly processes. In the

controlled precipitation process, 10 nm iron oxide-based nanocrystals (IONCs) were encapsulated into poly(ethylene

glycol) stabilized CNCs to make biocompatible T2 contrast agents. By adjusting the formulation, the CNC size was

tuned between 80 and 360 nm. Holding the CNC size constant at 99 nm ± 3 nm, the particle relaxivity varied linearly

with encapsulated IONC content ranging from 66 to 533 mM-1s-1 for CNCs with 4 to 16 wt% IONCs. By

functionalizing the CNC surface with hydroxyl groups, the CNCs targeted the liver. The CNCs darkened healthy liver

tissue, which enabled the detection of 0.8 mm3 non-small cell lung cancer metastases in vivo. Incorporation of the

hydrophobic NIR dye, PZn3, into CNCs enabled visualization with long wavelength fluorescence at 800 nm as well as

MRI imaging. Both the dye and IONC were encapsulated into the core of the CNCs. In vivo imaging demonstrated the

ability of these particles to act both as MRI and fluorescent imaging agents and to circulate in the blood over 24 hours.

To demonstrate the high drug-loading capabilities of CNCs formed via FNP, a theranostic CNC was created by the

single step, block copolymer-directed assembly of IONCs and itraconazole. The CNC had an ITZ drug loading of 47%.

Extended Abstract: File Not Uploaded